(MIT Technology Review) – One of the immune system’s roles is to detect and kill cells that have acquired cancerous mutations. However, some early-stage cancer cells manage to survive. A new study on colon cancer from MIT and the Dana-Farber Cancer Institute has identified one reason why: they turn on a gene called SOX17, which renders them essentially invisible to immune surveillance. (Read More)